# Executive Brief

## Decision

MeasureBridge ACO demonstrates an auditable operating pattern for quality specification, synthetic data validation, follow-up ownership, workflow evidence, and internal reporting review. It is a portfolio prototype, not a production reporting or clinical product.

## Demonstration result

The fixed synthetic cohort has 100 eligible source records. Sixty initially meet the educational documentation-completeness rule (60%). A constructed scenario that completes documentation for 15 initially `not_documented` records results in 75/100 (75%), or +15 percentage points. The denominator and original records remain fixed. The change is explicitly classified as documentation completion; it is not measured clinical improvement, care quality, reimbursement, or shared savings.

## Performance direction and rule boundary

The only executable rule is higher-is-better documentation completeness for an internally reviewed fictional rule, EDU-DOC-2026 v1.0.0. It is inspired by blood-pressure documentation but is not the CMS Controlling High Blood Pressure measure. No blood-pressure control threshold is applied. A future inverse measure such as glycemic status would require a separately specified, versioned lower-is-better rule and validated source definitions.

## Operational picture

The workspace separates missing documentation, uncompleted assessment, patient decline, data-pipeline defect, and unresolved eligibility. Assignments require an owner, role, due date, and barrier. A simulated point-of-care form records evidence and appends events without replacing source rows. Patient preference is preserved; no medication or treatment recommendation is generated. Reporting snapshots contain a digest and reconciliation; an independent ACO Operations reviewer is required, and unresolved results or open import errors block sign-off.

## Limitations and blockers

- All data and the commercial-contract label are fictional; no Bluestone terms are modeled.
- CMS pages provide context only. No official value sets, full CMS eligibility logic, LEAD measure logic, or submission format is implemented.
- The example is not FHIR interoperability and has no commercial EHR integration.
- The application has no production identity, role verification, PHI security, privacy guarantee, or deployment hardening.
- Burden values and workflow timing are assumptions, not observed productivity.
- The equity suppression is a display safeguard, not a formal privacy guarantee.

## Proposed next actions

1. Keep the educational prototype labeled and isolated from real patient or payer workflows.
2. Use the crosswalk, RACI, validation pack, calendar, and risk log to review workflow ownership and evidence requirements.
3. Before any real measure work, select a specific year and collection type, obtain exact specifications and value sets, implement every inclusion/exclusion/exception, and independently validate against known fixtures and expert chart review.
4. Before operational deployment, establish clinical governance, security/privacy controls, verified identity/authorization, audit/retention, support, and EHR interoperability validation.